Is LBPS or SPHD a better dividend investment in 2026?

LBPS currently yields 121.21% with a 5% 5-year dividend growth rate. SPHD yields 4.00% with 5% growth. The better choice depends on your goal: LBPS offers higher current income.

What is the dividend yield difference between LBPS and SPHD?

LBPS has a forward dividend yield of 121.21% ($2.00/share annually). SPHD yields 4.00% ($2.00/share annually). The yield gap is 117.21 percentage points.

Home › Compare › LBPS vs SPHD

LBPS vs SPHD: Dividend Comparison 2026

LBPS yields 121.21% · SPHD yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LBPS wins by $8.92M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LBPS

● Live price

121.21%

Share price

$1.65

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.95M

Annual income

$3,410,602.48

Full LBPS calculator →

SPHD

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full SPHD calculator →

Portfolio growth — LBPS vs SPHD

📍 LBPS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LBPS	SPHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LBPS + SPHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LBPS pays

SPHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBPS

Annual income on $10K today (after 15% tax)

$10,303.03/yr

After 10yr DRIP, annual income (after tax)

$2,899,012.11/yr

SPHD

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, LBPS beats the other by $2,898,247.80/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBPS + SPHD for your $10,000?

LBPS: 50%SPHD: 50%

100% SPHD50/50100% LBPS

Portfolio after 10yr

$4.49M

Annual income

$1,705,750.84/yr

Blended yield

38.02%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on LBPS right now

LBPS

Analyst Ratings

Buy

Hold

Consensus: Buy

SPHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBPS buys

SPHD buys

No recent congressional trades found for LBPS or SPHD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLBPSSPHD

Forward yield	121.21% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$8.95M	$28.0K ✓
Annual income after 10y	$3,410,602.48 ✓	$899.19
Total dividends collected	$8.14M ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: LBPS vs SPHD ($10,000, DRIP)

Year	LBPS Portfolio	LBPS Income/yr	SPHD Portfolio	SPHD Income/yr	Gap
1← crossover	$22,821	$12,121.21	$11,120	$420.00	+$11.7K → LBPS
2	$50,271	$25,852.41	$12,357	$458.31	+$37.9K → LBPS
3	$107,013	$53,222.70	$13,721	$499.76	+$93.3K → LBPS
4	$220,388	$105,884.01	$15,227	$544.58	+$205.2K → LBPS
5	$439,612	$203,797.23	$16,885	$593.02	+$422.7K → LBPS
6	$850,309	$379,924.02	$18,713	$645.34	+$831.6K → LBPS
7	$1,596,614	$686,783.92	$20,724	$701.81	+$1.58M → LBPS
8	$2,913,579	$1,205,201.50	$22,938	$762.73	+$2.89M → LBPS
9	$5,172,959	$2,055,429.68	$25,372	$828.41	+$5.15M → LBPS
10	$8,945,669	$3,410,602.48	$28,047	$899.19	+$8.92M → LBPS

LBPS vs SPHD: Complete Analysis 2026

LBPS — Stock

4D pharma plc, together with its subsidiaries, develops live biotherapeutic products (LBPs) in the United Kingdom. The company develops therapeutic candidates, including MRx0518 for the treatment of cancer and immune-oncology diseases; MRx-4DP0004 for the treatment of asthma; MRx0029 and MRx0005 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn's disease. It also develops products candidates, such as MRx1299 for solid tumors, MRx0006 for rheumatoid arthritis, and MRx0002 for multiple sclerosis. In addition, the company develops MicroRx platform to discover new LBP candidates for major diseases. 4D pharma plc has a collaboration agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate MRx0518; strategic collaboration agreement with University of Texas MD Anderson for discovery and development of LBPs in oncology; and Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda, MRx0518 in patients with solid tumors, and to discover and develop LBPs for vaccines. The company was formerly known as Schosween 18 Limited. 4D pharma plc was incorporated in 2014 and is headquartered in Leeds, the United Kingdom.

Full LBPS Calculator →

SPHD — ETF

SPHD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in SPHD shares.

Full SPHD Calculator →

📬

Get this LBPS vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBPS vs SCHD LBPS vs JEPI LBPS vs O LBPS vs KO LBPS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.